
News|Articles|April 25, 2008
Biovail receives approval for Aplenzin for depression
Aplenzin is a new drug from Biovail Corp. that has been approved to treat depression in adults
Advertisement
Aplenzin (bupropion hydrobromide), formerly known as BVF-033, is an antidepressant from Biovail Corp. that has just received approval from the Food & Drug Administration. The
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Long-Term Adverse Effects After COVID-19 Vaccination Vary by Brand
2
Individualized Approach Helps When Intensifying GLP-1 Therapy in T2D
3
Model Finds Weight Regain After Stopping Semaglutide or Tirzepatide
4
Meta-Analysis Identifies 5 Risk Factors for Post-COVID-19 Condition
5







































